110 related articles for article (PubMed ID: 21054671)
1. Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.
Briffa PJ; Anderson SD; Burton DL; Young IH
Respirology; 2011 Jan; 16(1):161-6. PubMed ID: 21054671
[TBL] [Abstract][Full Text] [Related]
2. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
Anderson SD; Brannan JD; Perry CP; Caillaud C; Seale JP
J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
Brannan JD; Anderson SD; Perry CP; Freed-Martens R; Lassig AR; Charlton B;
Respir Res; 2005 Dec; 6(1):144. PubMed ID: 16336673
[TBL] [Abstract][Full Text] [Related]
4. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
5. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol.
Anderson SD; Brannan J; Spring J; Spalding N; Rodwell LT; Chan K; Gonda I; Walsh A; Clark AR
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):758-65. PubMed ID: 9309990
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B;
Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
[TBL] [Abstract][Full Text] [Related]
7. Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management.
Cowan DC; Hewitt RS; Cowan JO; Palmay R; Williamson A; Lucas SJ; Murrell CJ; Thomas KN; Taylor DR
Respirology; 2010 May; 15(4):683-90. PubMed ID: 20337988
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.
Brannan JD; Gulliksson M; Anderson SD; Chew N; Seale JP; Kumlin M
Eur Respir J; 2006 May; 27(5):944-50. PubMed ID: 16707393
[TBL] [Abstract][Full Text] [Related]
9. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
Brannan JD; Koskela H; Anderson SD; Chan HK
Respirology; 2002 Mar; 7(1):37-44. PubMed ID: 11896899
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Daviskas E; Anderson SD; Eberl S; Young IH
Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma.
Brannan JD; Koskela H; Anderson SD; Chew N
Am J Respir Crit Care Med; 1998 Oct; 158(4):1120-6. PubMed ID: 9769270
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects.
Siffredi M; Mastropasqua B; Pelucchi A; Chiesa M; Marazzini L; Foresi A
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):238-43. PubMed ID: 9048536
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of inhaled terbutaline, sodium cromoglycate and budesonide on exercise-induced asthma in children.
Pichaipat V; Tongpenyai Y; Nerntong T; Sriprapachiranont C
J Med Assoc Thai; 1995 Oct; 78(10):505-8. PubMed ID: 8576655
[TBL] [Abstract][Full Text] [Related]
14. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)].
Imokawa S; Sato A; Taniguchi M; Toyoshima M; Nakazawa K; Hayakawa H; Chida K
Arerugi; 1992 Oct; 41(10):1515-20. PubMed ID: 1482300
[TBL] [Abstract][Full Text] [Related]
15. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects.
Brannan JD; Anderson SD; Freed R; Leuppi JD; Koskela H; Chan HK
Am J Respir Crit Care Med; 2000 Jun; 161(6):2096-9. PubMed ID: 10852793
[TBL] [Abstract][Full Text] [Related]
16. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G
Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
18. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
19. Asthma control in patients on fixed dose combination evaluated with mannitol challenge test.
Romberg KA; Berggren AC; Bjermer L
Respir Med; 2014 Feb; 108(2):264-70. PubMed ID: 24406244
[TBL] [Abstract][Full Text] [Related]
20. Onset of action of eformoterol by dry powder inhaler: objective and subjective measures.
Maesen FP; Smeets SJ; Costongs MA; Zweers PG; Pfeil JP
Br J Clin Pract; 1995; 49(6):294-6. PubMed ID: 8554951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
